| Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised … RM Anthenelli, NL Benowitz, R West, L St Aubin, T McRae, D Lawrence, ... The Lancet 387 (10037), 2507-2520, 2016 | 1160 | 2016 |
| Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review ND Volkow, JM Swanson, AE Evins, LE DeLisi, MH Meier, R Gonzalez, ... JAMA psychiatry 73 (3), 292-297, 2016 | 1005 | 2016 |
| The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach M Fava, AE Evins, DJ Dorer, DA Schoenfeld Psychotherapy and psychosomatics 72 (3), 115-127, 2003 | 516 | 2003 |
| Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis DC Henderson, E Cagliero, PM Copeland, CP Borba, AE Evins, ... Archives of general psychiatry 62 (1), 19-28, 2005 | 508 | 2005 |
| Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence AC Janes, DA Pizzagalli, S Richardt, BB Frederick, S Chuzi, G Pachas, ... Biological psychiatry 67 (8), 722-729, 2010 | 474 | 2010 |
| Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. DC Goff, C Cather, AE Evins, DC Henderson, O Freudenreich, ... Journal of Clinical Psychiatry 66 (2), 183-194, 2005 | 466 | 2005 |
| Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness DA Pizzagalli, AE Evins, EC Schetter, MJ Frank, PE Pajtas, DL Santesso, ... Psychopharmacology 196, 221-232, 2008 | 309 | 2008 |
| The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls RS Barr, MA Culhane, LE Jubelt, RS Mufti, MA Dyer, AP Weiss, ... Neuropsychopharmacology 33 (3), 480-490, 2008 | 308 | 2008 |
| Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study DC Henderson, DD Nguyen, PM Copeland, DL Hayden, CP Borba, ... Journal of Clinical Psychiatry 66 (9), 1116-1121, 2005 | 273 | 2005 |
| Optimizing real time fMRI neurofeedback for therapeutic discovery and development LE Stoeckel, KA Garrison, SS Ghosh, P Wighton, CA Hanlon, JM Gilman, ... NeuroImage: Clinical 5, 245-255, 2014 | 268 | 2014 |
| A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia AE Evins, VK Mays, C Cather, DC Goff, NA Rigotti, T Tisdale Nicotine & tobacco research 3 (4), 397-403, 2001 | 260 | 2001 |
| Placebo-controlled trial of glycine added to clozapine in schizophrenia AE Evins, SM Fitzgerald, L Wine, R Rosselli, DC Goff American Journal of Psychiatry 157 (5), 826-828, 2000 | 257 | 2000 |
| A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia AE Evins, C Cather, T Deckersbach, O Freudenreich, MA Culhane, ... Journal of clinical psychopharmacology 25 (3), 218-225, 2005 | 254 | 2005 |
| Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial AE Evins, C Cather, SA Pratt, GN Pachas, SS Hoeppner, DC Goff, ... Jama 311 (2), 145-154, 2014 | 248 | 2014 |
| A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia DC Goff, DC Henderson, AE Evins, E Amico Biological psychiatry 45 (4), 512-514, 1999 | 239 | 1999 |
| Initiating pharmacologic treatment in tobacco-dependent adults. An official American Thoracic Society clinical practice guideline FT Leone, Y Zhang, S Evers-Casey, AE Evins, MN Eakin, J Fathi, ... American journal of respiratory and critical care medicine 202 (2), e5-e31, 2020 | 225 | 2020 |
| Opioid antagonists for smoking cessation SP David, T Lancaster, LF Stead, AE Evins, JJ Prochaska Cochrane Database of Systematic Reviews, 2013 | 214 | 2013 |
| A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia AE Evins, C Cather, MA Culhane, A Birnbaum, J Horowitz, E Hsieh, ... Journal of clinical psychopharmacology 27 (4), 380-386, 2007 | 213 | 2007 |
| Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight O Freudenreich, C Cather, AE Evins, DC Henderson, DC Goff Journal of Clinical Psychiatry 65 (10), 1372-1376, 2004 | 202 | 2004 |
| Folate, homocysteine, and negative symptoms in schizophrenia DC Goff, T Bottiglieri, E Arning, V Shih, O Freudenreich, AE Evins, ... American Journal of Psychiatry 161 (9), 1705-1708, 2004 | 194 | 2004 |
Donald GoffNYU School of MedicineVerified email at nyumc.org
